0001179110-12-006484.txt : 20120404 0001179110-12-006484.hdr.sgml : 20120404 20120404181813 ACCESSION NUMBER: 0001179110-12-006484 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120402 FILED AS OF DATE: 20120404 DATE AS OF CHANGE: 20120404 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MARTIN JOHN C CENTRAL INDEX KEY: 0001190578 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19731 FILM NUMBER: 12743253 MAIL ADDRESS: STREET 1: 333 LAKESIDE DRIVE CITY: FOSTER CITY STATE: X1 ZIP: 94404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GILEAD SCIENCES INC CENTRAL INDEX KEY: 0000882095 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943047598 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6505743000 MAIL ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 4 1 edgar.xml FORM 4 - X0305 4 2012-04-02 0 0000882095 GILEAD SCIENCES INC GILD 0001190578 MARTIN JOHN C GILEAD SCIENCES, INC. 333 LAKESIDE DRIVE FOSTER CITY CA 94404 1 1 0 0 Chairman and CEO Common Stock 2012-04-02 4 M 0 145450 8.9425 A 2134655 D Common Stock 2012-04-02 4 S 0 145450 48.3798 D 1989205 D Non-Qualified Stock option (right to buy) 8.9425 2012-04-02 4 M 0 145450 0 D 2013-01-28 Common Stock 145450 1152470 D The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested. The exercise and sale transactions reported in this Form 4 made pursuant to a Rule 10b5-1 trading plan established by Dr. Martin on December 12, 2011. Sale prices reported for the transactions reported here range from $47.86 to $48.78. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. /s/ John C. Martin 2012-04-04